Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 23: 2263-2274, 1977;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bretaudiere, J. P.
Right arrow Articles by Bailly, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bretaudiere, J. P.
Right arrow Articles by Bailly, M.

Clinical Chemistry, Vol 23, 2263-2274, Copyright © 1977 by American Association for Clinical Chemistry

Criteria for establishing a standardized method for determining alkaline phosphatase activity in human serum

JP Bretaudiere, A Vassault, L Amsellem, ML Pourci, H Thieu-Phung and M Bailly

We investigated factors influencing alkaline phosphatase activity in the course of developing criteria for the establishment of a standardized method for its determination in human serum at 30 degrees C. The effects of pH, phosphorylatable acceptor (2-amino-2-methyl-1- propanol and diethanolamine), 4-nitrophenyl phosphate, magnesium ion, zinc ion, temperature, volume fraction of specimen, and details of initiation of the reaction have been studied, with use of partly purified enzymes from bone, intestine, liver, and placenta, and sera from patients with a predominant characterized isoenzyme. The purity of the diethanolamine was examined and contaminant monoethanolamine was characterized as a competitive inhibitor. Two sets of recommended conditions are: 2-amino-2-methyl-1-propanol, 0.9 mol/liter; 4- nitrophenyl phosphate, 16 mmol/liter; magnesium ion, 1 mmol/liter; volume fraction of specimen 1/30, and pH30 degrees C 10.5; diethanolamine, 1.8 mol/liter; 4-nitrophenyl phosphate, 18 mmol/liter; magnesium ion, 1 mmol/liter; volume fraction of specimen 1/60, and pH30 degrees C 10.1. Serum is preincubated with all reagents but 4- nitrophenyl phosphate, which is used as the reaction-initiating substrate.


The following articles in journals at HighWire Press have cited this article:


Home page
 Toxicol PatholHome page
L. Atencio, I. Moreno, A. I. Prieto, R. Moyano, A. M. Molina, and A. M. Camean
Acute Effects of Microcystins MC-LR and MC-RR on Acid and Alkaline Phosphatase Activities and Pathological Changes in Intraperitoneally Exposed Tilapia Fish (Oreochromis sp.)
Toxicol Pathol, April 1, 2008; 36(3): 449 - 458.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
D. R. Mager, L. J. Wykes, E. A. Roberts, R. O. Ball, and P. B. Pencharz
Mild-to-Moderate Chronic Cholestatic Liver Disease Increases Leucine Oxidation in Children
J. Nutr., April 1, 2006; 136(4): 965 - 970.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
D. R. Mager, L. J. Wykes, E. A. Roberts, R. O. Ball, and P. B. Pencharz
Branched-Chain Amino Acid Needs in Children with Mild-to-Moderate Chronic Cholestatic Liver Disease
J. Nutr., January 1, 2006; 136(1): 133 - 139.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1977 by the American Association for Clinical Chemistry.